Status:
UNKNOWN
The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis
Lead Sponsor:
Assiut University
Conditions:
Hepatitis C
Eligibility:
All Genders
18-70 years
Brief Summary
Hepatitis is known to induce severe liver diseases. The evaluation of the severity of liver cirrhosis is very important for the selection of appropriate treatment plan and the monitoring of patient re...
Detailed Description
Introduction Hepatitis is known to induce severe liver diseases such as liver cirrhosis and liver cancer which are serious threats to public health. The evaluation of the severity of liver cirrhosis i...
Eligibility Criteria
Inclusion
- Hepatitis C positive patients with Child-Pugh (A) classification.
Exclusion
- Advanced liver cirrhosis with decompensated liver or patients with malignant hepatic focal lesions.
- Cases with proven structural abnormalities, history of liver disease or risk factors of liver disease will be excluded from healthy controls.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03456440
Start Date
April 1 2019
End Date
May 1 2020
Last Update
March 7 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.